ABHD16A

Chr 6AR

abhydrolase domain containing 16A, phospholipase

Also known as: BAT5, D6S82E, NG26, PP199, SPG86, hBAT5

ABHD16A encodes a phosphatidylserine lipase that hydrolyzes phosphatidylserine to generate lysophosphatidylserine, a signaling lipid that regulates neurological processes. Mutations cause autosomal recessive spastic paraplegia 86, characterized by progressive spasticity primarily affecting the lower extremities. The gene shows high constraint against loss-of-function variants (LOEUF 0.384), suggesting intolerance to protein-disrupting changes.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.381 OMIM phenotype
Clinical SummaryABHD16A
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.22) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.38LOEUF
pLI 0.473
Z-score 4.63
OE 0.22 (0.130.38)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.48Z-score
OE missense 0.62 (0.550.69)
207 obs / 334.6 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.22 (0.130.38)
00.351.4
Missense OE0.62 (0.550.69)
00.61.4
Synonymous OE0.88
01.21.6
LoF obs/exp: 9 / 40.9Missense obs/exp: 207 / 334.6Syn Z: 1.02

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ABHD16A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →